Cerebrolysin

Medicinal product

(Invented) name

Cerebrolysin

Active substance (s)

Kiaulių smegenų peptidų preparatas (Cerebrolysin koncentratas)

Strength

215,2 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N06BX, Other psychostimulants and nootropics

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-04-01

Date of renewal

Documents

3277_Cerebrolysin 215,2mg-ml_inj_inf_tirp_PZ_2026-04-01.docx

3277_Cerebrolysin 215,2mg-ml_inj_inf_tirp_PL_2026-04-01.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Viename ml tirpalo yra	1 ml
Kiaulių smegenų peptidų preparatas (Cerebrolysin koncentratas)	215,2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
120406	106510	1106510	ampulė	5 ml N5		Receptinis	LT/L/26/3277/001	Netiekiama	-	-	No	-	-	Download
120407	106511	1106511	ampulė	10 ml N5		Receptinis	LT/L/26/3277/002	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-04-01	Registruotas